PB
PDS Biotechnology Corp
🇩🇪XFRA.EU6GermanyHealthcare
€0.37EURup +0.12 (+48%)OpenEnd of day6:09 PM
Price€0.37+0.12 (+48%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US70465T1079
- CUSIP
- Not reported
Company
- Employees
- 21
- Headquarters
- Princeton, United States
- Website
- https://www.pdsbiotech.com
- CEO
- Dr. Frank K. Bedu-Addo Ph.D.
Market
- Shares outstanding
- 55.8M
- Market cap
- €20.65M
Highlights
- Market cap
- €20.65M
- EPS LTM
- -$0.60
- P/E LTM
- -1.45
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$33.67M+8.01%up year on year
- Gross margin
- Not reported
- Free cash flow
- -$16.78M+51.17%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.